The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Ph III randomized studies of the oral pan-PI3K inhibitor buparlisib (BKM120) with fulvestrant in postmenopausal women with HR+/HER2– locally advanced or metastatic breast cancer (BC) after aromatase inhibitor (AI; BELLE-2) or AI and mTOR inhibitor (BELLE-3) treatment.
Hiroji Iwata
Honoraria - Novartis
José Baselga
Consultant or Advisory Role - Novartis
Mario Campone
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Carlos L. Arteaga
No relevant relationships to disclose
Javier Cortes
Consultant or Advisory Role - Celgene; Novartis; Roche
Honoraria - Celgene; Eisai; Novartis; Roche
Walter Jonat
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Michelino De Laurentiis
Consultant or Advisory Role - AstraZeneca; Novartis; Roche
Honoraria - AstraZeneca; Novartis; Roche
Eva Ciruelos
No relevant relationships to disclose
Wolfgang Janni
Honoraria - Novartis
Research Funding - Novartis
Thomas Bachelot
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Per Eystein Lonning
No relevant relationships to disclose
Cynthia Ma
Consultant or Advisory Role - Novartis (U)
Research Funding - Novartis
Ruth O'Regan
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Emmanuelle Di Tomaso
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Bharani Bharani-Dharan
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Vincent Duval
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Helen Lau
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Caroline Germa
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Patrick Urban
Employment or Leadership Position - Novartis
Angelo Di Leo
Consultant or Advisory Role - AstraZeneca; Novartis; Pfizer
Honoraria - AstraZeneca; Novartis; Pfizer
Research Funding - Novartis; Pfizer